Mr. Speaker, here is another document, just to show the seriousness of this issue. It is an interoffice memo from Connaught Laboratories, the subsidiary of CDC. The Minister of Finance was on the board of directors at that time. The memo is dated 1983. It says “In view that Connaught's blood products are not yet registered in most countries, nor do we have heat-treated products, it is essential that we capitalize on every inquiry that we may receive”.
In other words, Connaught Laboratories was trying to sell a product, which would not be allowed in the United States or Canada, abroad. This was during the time the Minister of Finance was on the board of directors of the CDC.
Will the Prime Minister be able to assure us that these kinds of memos from Connaught Laboratories are part of this—